Regulatory Challenges in the COVID-19 Era: The Case of Tunisia

In view of the possible disruptions in the manufacturing and supply of health products following the coronavirus disease 2019 (COVID-19) pandemic, the Tunisian medicines regulatory authority was mobilized to guarantee patient safety. Teleworking has become the ultimate way of service continuity. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Cherif, Dora, Felfel, Hajer, Drira, Chema, Aounallah, Mariam, Kadri, Meriem, Ben Rayana, Mohamed Chiheb, Razgallah Khrouf, Myriam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2020
Materias:
Report from the Field
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943945/
https://www.ncbi.nlm.nih.gov/pubmed/33143805
http://dx.doi.org/10.1017/dmp.2020.432

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943945/
https://www.ncbi.nlm.nih.gov/pubmed/33143805
http://dx.doi.org/10.1017/dmp.2020.432

Ejemplares similares